Demand for cannabidiol (CBD) in the Health and Wellness sector continues to grow at a rapid pace. One reason investors are keen on the industry is that unlike hemp and marijuana-derived products containing THC, CBD products are federally legal.
This has caused several research outlets to forecast impressive growth in the industry. According to ResearchAndMarkets, the CBD-infused Products Market is expected to reach $216.8 billion by 2028, at a CAGR of 45.6% during the forecast period, 2021-2028.
This makes finding the best opportunities in the sector paramount to wise investors. We’ve found a few CBD plays worth researching:
Southern ITS International, Inc. (OTCMKTS:SITS) is a holding company that is entering the CBD market through Restorative Health & Wellness, Inc., a Newport Beach, CA based-company known for its all-natural RESTAURA line of skin, health, and wellness products, which incorporate cannabidiol CBD as a primary active ingredient. James Shipley, SITS’ CEO, on the acquisition, “We are excited at the prospect of our investment in Restorative Health & Wellness and look forward to finalizing the stock for stock transaction. The RESTAURA product line is an example of unique innovation. We believe that it will become a leader in the skincare and wellness industry with products that restore and rejuvenate the human spirit.”
HempFusion Wellness Inc. (OTCMKTS:CBDHF) is a leading health and wellness company whose family of premium consumer brands include HempFusion™, Sagely Naturals™, Apothecanna™, and Probulin Probiotics™, the company announced November 4th, that another Top 15 US supermarket chain has launched HempFusion products in the Southeast United States. HempFusion’s OTC (Over-the-Counter)) Pain Relief Cream will be added to approximately 400 stores and HempFusion’s Ingestible and Topical CBD products will now be available in 75 targeted stores.
cbdMD, Inc. (NYSE:YCBD) produces a comprehensive line of U.S.-produced, THC-free1 CBD products. The cbdMD brand currently includes over 130 SKUs of high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD bath bombs, CBD bath salts, CBD sleep aids, CBD drink mixes and full spectrum CBD options. The company announced the appointment of Matt Coapman as the Chief Marketing Officer earlier this month. “Matt brings over 15 years of experience in the world of digital marketing and ecommerce strategy execution to the company. Since 2016, Matt has been a Partner at consumer goods think tank Dingoz Consulting, where he helped clients with their product launches and ecommerce development.”
Charlotte’s Web Holdings Inc. (OTCMKTS:CWBHF) headquartered in Denver, Colorado, produces innovative hemp extract wellness products under a family of brands which includes Charlotte’s Web™, CBD Medic™, CBD Clinic™, and Harmony Hemp™. The company will be releasing its Q3 numbers on November 15th.
Zynerba Pharmaceuticals Inc. (Nasdaq:ZYNE) specializes in pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders including Fragile X syndrome, autism spectrum disorder, 22q11.2 deletion syndrome, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. The company recently presented at Society for Developmental & Behavioral Pediatrics Annual Meeting, October 21-25, 2021, and the 68th American Academy of Child & Adolescent Psychiatry Annual Meeting, October 18-30, 2021.